Introduction
Helix BioPharma’s financial statements and related MD&A are archived on this web site for historical purposes only. Specific information included in these documents may change over time, and may or may not be accurate after the date on the documents. Helix BioPharma has no intention and specifically disclaims any duty to update the information in these documents.
For financial information earlier than the dates listed below, please go to www.sedar.com. Security holders may obtain a hard copy of our audited financial statements free of charge from the Chief Financial Officer of the issuer, by writing to him at: 2704, 401 Bay Street, Toronto M5H2Y4, by telephone: 905-841-2300, e-mail: ir@helixbiopharma.com.
